CAV1 and prostate carcinoma: In prostate cancer however, overwhelming evidence implicates Cav-1 as being associated with, and mediating, increased aggressiveness; Cav-1 overexpression in prostate cancer clinical samples correlates with disease stage [16], grade [17], metastasis [16], androgen insensitivity [18] angiogenesis [19] and poor outcome [20].